ABT · News · 20261022N

Revenue Performance and Mix

ABBOTT LABORATORIES · 2026-10-22 · Importance 36 · Surprise 14

Abbott reported approximately 7% comparable sales growth in the third quarter of 2026. Adjusted earnings per share was $1.42, matching the level management had indicated. Third-quarter Nutrition sales benefited from stronger pediatric and adult nutrition demand despite mixed results for the division during the first nine months of 2026. Abbott also reported higher gross and operating margins in the quarter.

Key facts

• Abbott reported comparable sales growth of roughly 7% and adjusted earnings per share of US$1.42 for Q3 2026. source